SCHEMBL20102390

SCHEMBL20102390

CCCCCOc1ccc2c(c1F)-c1c-2cc(OCC)c(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.42
THRB P10828 5/20 0.38
THRA P10827 4/20 0.38
FGFR2 P21802 1/20 0.36
S1PR2 O95136 2/20 0.36
S1PR1 P21453 2/20 0.36
S1PR3 Q99500 2/20 0.36
LPAR2 Q9HBW0 2/20 0.36
TDP1 Q9NUW8 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
CHUK O15111 1/20 0.35
DAPK3 O43293 1/20 0.35
JAK2 O60674 1/20 0.35
ROCK2 O75116 1/20 0.35
PRKCG P05129 1/20 0.35
CDK1 P06493 1/20 0.35
PIM1 P11309 1/20 0.35
RPS6KB1 P23443 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20102408 0.86 THRB (0.39) THRBTHRAS1PR2S1PR1S1PR3
SCHEMBL20111247 0.85 L3MBTL1 (0.35) L3MBTL1THRBTHRAFGFR2TDP1
SCHEMBL20102464 0.83 SMPD1 (0.41) L3MBTL1MAPTALDH1A1RAB9AGAA
SCHEMBL20102405 0.83 FGFR2 (0.34) L3MBTL1THRBFGFR2TDP1MAPT
SCHEMBL20102406 0.83 THRB (0.37) L3MBTL1THRBTHRAS1PR1CHUK
SCHEMBL15120821 0.83 L3MBTL1 (0.56) L3MBTL1THRBTHRAS1PR2S1PR1
SCHEMBL20102461 0.82 PPARG (0.32) THRBTHRAHPGDALDH1A1PLA2G2D
SCHEMBL20102417 0.82 THRB (0.38) THRBTHRAS1PR2S1PR1S1PR3
SCHEMBL20102409 0.81 ESR1 (0.38) L3MBTL1THRBTHRACYP1A2CYP2C19
SCHEMBL19160420 0.81 L3MBTL1 (0.55) L3MBTL1THRBTHRAS1PR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2019-06-18 US disclosed
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-05-03 US disclosed
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-05-03 US disclosed
EP-3315583-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2018-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE YBX1, PIEZO1, C1S L3MBTL1 177/4885THRB 3964/4885THRA 3521/4885
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device YBX1, PIEZO1, C1S L3MBTL1 177/4885THRB 3964/4885THRA 3521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.